Search results
‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.
Washington Post· 3 days agoIt was 2021, a year into the coronavirus pandemic, and as he slid into a chair, Patel shared that...
This Unexpected Pain Is a Common Sign of Prostate Cancer, According to Urologists
Parade via AOL· 3 days agoMan discussing prostate cancer signs with his doctor Prostate cancer is one of the most common types...
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 6 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
Virtua Health Implements Groundbreaking Lung Cancer Technology
New Jersey Business Magazine· 2 days agoVirtua Health is the first provider in South Jersey to offer this important advancement, called...
Lung cancer treatment produces progression-free survival results in Phase III trial
Medical Xpress· 3 days agoOsimertinib, produced by AstraZeneca under the brand name Tagrisso, significantly extends the time patients live without their cancer worsening, offering the first effective ...
Hundreds gather to fight back against cancer at Relay for Life of CNY
Rome Sentinel· 2 hours agoNearly 60 teams and over 500 participants came together to celebrate local cancer survivors, honor...
Alan Kaufman tells his story at Zuckerberg Cancer Center's Cancer Survivors Day
Newsday· 2 hours agoDoctors discovered tumors in Kaufman's brain and a large lesion in his left lung, which required...
Artery Inflammation and CV Events; Stepped Palliative Care for Lung Cancer Patients
MedPage Today· 19 hours agoTTHealthWatch is a weekly podcast from Texas Tech. This week's topics include stepped palliative...
AstraZeneca immunotherapy extends survival by two years in rarer type of lung cancer
BioPharma Dive via Yahoo Finance· 7 days agoAstraZeneca’s immunotherapy Imfinzi helped people in the early stages of a type of lung cancer live...
New Lung Cancer Drug Trial Hailed As Best Result Ever, Setting A “New Benchmark”
IFLScience· 5 days agoPhase III trial results for a new drug targeting advanced lung cancer have just been reported, with...